Eflornithine oral - Panbela Therapeutics
At a glance
- Drug Originator Cancer Prevention Pharmaceuticals
- Drug Licenced by Norgine; US WorldMeds
- Drug Class Antihyperglycaemics; Antineoplastics; Basic amino acids; Diamino amino acids; Small molecules
- Mechanism of Action Ornithine decarboxylase inhibitors
- USA Patent Applicants USWM
- NDAs 1
- Patent Applications 4,153
Table of Contents

Disclaimer